First Ever Meme Currency company

Common information
Company name
Repligen
Legal name
Repligen Corporation
Address
41 Seyon Street Building #1, Suite 100
Country
USA
Description
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Total funding
$1,518,225,000
Employee count
n/a

Company funding rounds

Round Announced on Number of investors Raised
Grant Dec. 15, 2010 $1,400,000
Post IPO Equity June 18, 2014 $4,000,000
Post IPO Equity April 30, 2019 $175,000,000
Post IPO Debt July 19, 2019 $287,500,000
Post IPO Equity July 19, 2019 $138,100,000
Post IPO Equity Dec. 7, 2020 $312,225,000
Post IPO Debt Dec. 6, 2023 $600,000,000
No investors data yet